According to a new report, published by KBV research, The Global Neuroscience Market size is expected to reach $64 billion by 2030, rising at a market growth of 5.5% CAGR during the forecast period.
The Consumables segment is exhibiting a CAGR of 6.1% during (2023 - 2030). Consumables refers to a wide range of products required for neuroscience research. Due to the increasing prevalence of neuroscience technology experiments, increased demand for consumables is anticipated to drive the consumables segment throughout the forecast period and highlight its lucrative nature.
The Brain Imaging segment is leading the Global Neuroscience Market by Technology in 2022; thereby, achieving a market value of $16.3 billion by 2030. This growth can be associated with the increased use of brain imaging tools in hospitals, diagnostic facilities, and ambulatory surgery centers (ASCs), such as MRI, EEG, and CT scans, to diagnose neurological illnesses. According to the National Health Service (NHS) England and NHS Improvement Report 2022, doctors recommended roughly 67,215 patients in March 2022 for brain MRI scans to diagnose cancer.
The Hospitals segment is capturing a CAGR of 5.9% during (2023 - 2030). The expansion of the segment is due to the rising number of people with neurological illness conditions being admitted to hospitals. The National Center for Biotechnology Information (NCBI) estimates that 22.6 million people worldwide experience neurological injuries or diseases yearly, 13.8 million of whom need surgery.
The North America region dominated the Global Neuroscience Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $22.8 billion by 2030. The Europe market is anticipated to grow at CAGR of 5.3% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 6.2% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/neuroscience-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Carl Zeiss AG, Danaher Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Terumo Corporation, B. Braun Melsungen AG, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories
By Component
By Technology
By End User
By Geography
Companies Profiled
Unique Offerings 
